Taking blood thinners one year after atrial fibrillation ablation
Part of Heart & circulation clinical trials.
This study looks at whether people who have stayed in normal rhythm one year after atrial fibrillation ablation should continue blood thinning treatment. It may help guide safer, more personalized choices about long-term blood thinners after a successful procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had atrial fibrillation treated with catheter ablation, and your atrial fibrillation has not returned for the past year
- Your stroke-risk score is at least 1 for men or at least 2 for women
- You are between 19 and 80 years old
- Your atrial fibrillation is not caused by a heart valve problem
- You can give consent and can be followed up after joining the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a rhythm-guided approach to using blood thinners (antithrombotics) is safe and effective for people who have had both a heart stent and a successful ablation for atrial fibrillation. It may help you avoid unnecessary medication while preventing strokes and bleeds.
This study tests a 'pill-in-the-pocket' approach for blood thinners after a catheter ablation for atrial fibrillation. Instead of taking a daily blood thinner, you may only take it when needed, which could reduce the risk of bleeding while still preventing strokes.
This trial follows people with atrial fibrillation to see how long-term blood-thinning treatment affects outcomes over time. It may help determine which long-term approach best lowers stroke and clot risks for patients like you.
This trial tests whether it is safe to stop taking blood thinners (anticoagulants) after a successful ablation procedure for atrial fibrillation. If you have had no AF for 3 months after your first ablation, you may be able to stop these medications, reducing your risk of bleeding.
This study follows people with atrial fibrillation to see how well blood-thinning medications work and what outcomes they experience over time. It aims to improve treatment guidance for patients with this common heart rhythm condition.
This trial tests whether people with atrial fibrillation who have had a successful ablation procedure can safely stop taking blood thinners (NOACs) if they wear a monitor to check for any silent heart rhythm problems. It may help you avoid the risks of long-term blood thinner use if your ablation has been effective.
Hear when a new Atrial Fibrillation Patients With Moderate or High Stroke Risk Who Had Undergone Catheter Ablation of Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.